SUBSCRIBERS

In Brief

Published Tue, Jan 6, 2015 · 09:50 PM

QT Vascular clinical trial exceeds patient enrolment goal

QT VASCULAR said that the clinical trial for its Chocolate® Touch drug-coated balloon in Europe and New Zealand has "substantially exceeded" its patient enrolment goal for Q4 2014. The company expects to obtain CE marking regulatory approval for the product in the second half of 2015, which would allow it to market the product in the European Union.

BBB+ rating for AG Trust's golf course holding company